Although almost four of seven million persons living with HIV on antiretroviral therapy (ART), an additional 2.5 million individuals must be initiated on ART to reach the target of initiating 90% of diagnosed HIV positive patients on ART by 2020. However, an estimated 20% of South African patients eligible under CD4<200 eligibility threshold were likely to refuse ART. With the removal of CD4 eligibility thresholds in 2016, it is unclear whether the demand for ART has improved and understanding correlates of HIV treatment readiness and ART acceptability among high CD4 patients is limited. This study aims to accomplish the following: 1. To estimate the rate of ART refusals up to six months after HIV diagnosis among adults diagnosed with HIV under the UTT policy in the Gauteng province, South Africa. 2. To describe patient-level correlates of readiness to initiate ART among newly diagnosed HIV positive patients with high baseline CD4 count (>350 cells/µl) in the Gauteng province, South Africa
The following publications emanate from this project:
HE2RO staff involvedDr Dorina Onoya Idah Mokhele Tembeka Sineke Julia Mogwasi Nokukhanya Mhlanga
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.